Cargando…

Improvement in health-related quality of life in osteoporosis patients treated with teriparatide

BACKGROUND: Individuals with osteoporosis and recent vertebral fractures suffer from pain and impaired health-related quality of life (HRQL). To determine whether patients with osteoporosis treated with teriparatide experienced improvement in HRQL and pain symptoms after several months of therapy. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lau, Arthur N, Ali, Sammy H, Sawka, Anna M, Thabane, Lehana, Papaioannou, Alexandra, Gafni, Amiram, Adachi, Jonathan D
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2588585/ https://www.ncbi.nlm.nih.gov/pubmed/18990249 http://dx.doi.org/10.1186/1471-2474-9-151

Ejemplares similares

Does Alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women
por: Sawka, Anna M, et al.
Publicado: (2005)

The utilization of appropriate osteoporosis medications improves following a multifaceted educational intervention: the Canadian quality circle project (CQC)
por: Ioannidis, George, et al.
Publicado: (2009)

Optimizing care in osteoporosis: The Canadian quality circle project
por: Ioannidis, George, et al.
Publicado: (2008)

Role of teriparatide in treatment of glucocorticoid-induced osteoporosis
por: Lau, Arthur N, et al.
Publicado: (2010)

Measurement of fractionated plasma metanephrines for exclusion of pheochromocytoma: Can specificity be improved by adjustment for age?
por: Sawka, Anna M, et al.
Publicado: (2005)

A Scoping Review of Strategies for the Prevention of Hip Fracture in Elderly Nursing Home Residents
por: Sawka, Anna M., et al.
Publicado: (2010)

A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytoma
por: Sawka, Anna M, et al.
Publicado: (2004)

An overview of osteoporosis and frailty in the elderly
por: Li, Guowei, et al.
Publicado: (2017)

Corrigendum to “Risk Factors for Fracture in Diabetes: The Canadian Multicentre Osteoporosis Study”
por: Fraser, Lisa-Ann, et al.
Publicado: (2017)

Exploring participant attrition in a longitudinal follow-up of older adults: the Global Longitudinal Study of Osteoporosis in Women (GLOW) Hamilton cohort
por: Okpara, Chinenye, et al.
Publicado: (2023)

The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women
por: Hopkins, Robert B, et al.
Publicado: (2011)

Comparison between Frailty Index of Deficit Accumulation and Phenotypic Model to Predict Risk of Falls: Data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) Hamilton Cohort
por: Li, Guowei, et al.
Publicado: (2015)

Teriparatide in the management of osteoporosis
por: Bodenner, Donald, et al.
Publicado: (2007)

Frailty index of deficit accumulation and falls: data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) Hamilton cohort
por: Li, Guowei, et al.
Publicado: (2014)

Do patients perceive a link between a fragility fracture and osteoporosis?
por: Giangregorio, Lora, et al.
Publicado: (2008)

Community Program Improves Quality of Life and Self‐Management in Older Adults with Diabetes Mellitus and Comorbidity
por: Markle‐Reid, Maureen, et al.
Publicado: (2017)

Understanding and Managing Corticosteroid-Induced Osteoporosis
por: Kobza, Alexandra O, et al.
Publicado: (2021)

Teriparatide – Indications beyond osteoporosis
por: Cheng, Marilyn Lee, et al.
Publicado: (2012)

Therapy of Osteoporosis in Men with Teriparatide
por: Cusano, Natalie E., et al.
Publicado: (2011)

Effect of teriparatide on quality of life in patients with postmenopausal osteoporosis: a retrospective cohort study
por: Yang, Tiansong, et al.
Publicado: (2019)

New simulation model for bone formation markers in osteoporosis patients treated with once-weekly teriparatide
por: Tanaka, Sakae, et al.
Publicado: (2014)

Profile of teriparatide in the management of postmenopausal osteoporosis
por: Sikon, Andrea, et al.
Publicado: (2010)

Teriparatide for osteoporosis: importance of the full course
por: Lindsay, R., et al.
Publicado: (2016)

Treatment of osteoporosis with teriparatide: The Slovenian experience
por: Kocjan, Tomaz, et al.
Publicado: (2021)

Effective osteoporosis treatment with teriparatide is associated with enhanced quality of life in postmenopausal women with osteoporosis: the European Forsteo Observational Study
por: Ljunggren, Östen, et al.
Publicado: (2013)

Analysis and reporting of stratified cluster randomized trials—a systematic survey
por: Borhan, Sayem, et al.
Publicado: (2020)

Performance of methods for analyzing continuous data from stratified cluster randomized trials – A simulation study
por: Borhan, Sayem, et al.
Publicado: (2023)

Competing interests in development of clinical practice guidelines for diabetes management: Report from a multidisciplinary workshop
por: Sawka, Anna M, et al.
Publicado: (2008)

Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer - a randomized controlled trial
por: Sawka, Anna M, et al.
Publicado: (2010)

Management of glucocorticoids-induced osteoporosis: role of teriparatide
por: Migliaccio, Silvia, et al.
Publicado: (2009)

A Case of Teriparatide on Pregnancy-Induced Osteoporosis
por: Lee, Seok Hong, et al.
Publicado: (2013)

Update on the safety and efficacy of teriparatide in the treatment of osteoporosis
por: Minisola, Salvatore, et al.
Publicado: (2019)

Osteoporotic fractures and obesity affect frailty progression: a longitudinal analysis of the Canadian multicentre osteoporosis study
por: Gajic-Veljanoski, Olga, et al.
Publicado: (2018)

Fractures are increased and bisphosphonate use decreased in individuals with insulin-dependent diabetes: a 10 year cohort study
por: Fraser, Lisa-Ann, et al.
Publicado: (2014)

An empirical comparison of methods for analyzing over-dispersed zero-inflated count data from stratified cluster randomized trials
por: Borhan, Sayem, et al.
Publicado: (2020)

Teriparatide vs. Alendronate as a treatment for osteoporosis: Changes in biochemical markers of bone turnover, BMD and quality of life
por: Panico, Annalisa, et al.
Publicado: (2011)

Treatment responses with once-weekly teriparatide therapy for osteoporosis
por: Shiraki, M., et al.
Publicado: (2016)

The reporting and handling of missing data in longitudinal studies of older adults is suboptimal: a methodological survey of geriatric journals
por: Okpara, Chinenye, et al.
Publicado: (2022)

An update of the prevalence of osteoporosis, fracture risk factors, and medication use among community-dwelling older adults: results from the Canadian Longitudinal Study on Aging (CLSA)
por: McArthur, Caitlin, et al.
Publicado: (2022)

Reporting quality of pilot clinical trials in chronic kidney disease patients on hemodialysis: a methodological survey
por: Kosa, Sarah Daisy, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hlbi4njl7718i9fai5pf4ifli0